# MAGNESIUM STEARATE

URL: https://app.greenveil.ai/ingredients/ingredient_dtxsid_dtxsid2027208
Categories: beauty, cleaning, food, industrial, pharma
Functions: Anti-adhesive/cohesive, Anti-caking agent, Binder, Dye, Filler, Flavouring and nutrient, Heat stabilizer, Humectant, Lubricating agent, Processing aids not otherwise specified, Surfactant (surface active agent), Thickening agent
Identifier: DTXSID2027208

> MAGNESIUM STEARATE is used as anti-adhesive/cohesive / anti-caking agent. EPA CPDat observed this chemical in 1409 composition records across product categories including Raw materials, Construction and building materials, Food and drug. Assessed from 45 sources.

## Safety assessment

- Chemical concern: not yet assessed
- Rationale: EPA CPDat observed this chemical in 1409 composition records across product categories including Raw materials, Construction and building materials, Food and drug.

## Regulatory status

- US: commercial use observed — EPA CPDat observed this chemical in 1409 composition records across product categories including Raw materials, Construction and building materials, Food and drug. EPA CPDat classifies this chemical for functional uses including Surfactant (surface active agent), Anti-caking agent, Dye.
- US: inactive ingredient database — Route: BUCCAL; Dosage form: TABLET; Potency: 17.5 mg
- US: inactive ingredient database — Route: INTRAVITREAL; Dosage form: IMPLANT; Potency: NA
- US: inactive ingredient database — Route: INTRAVITREAL; Dosage form: SYSTEM; Potency: 0.02 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE; Potency: 256.4 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED PELLETS; Potency: 0.15 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, COATED, EXTENDED RELEASE; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, DELAYED RELEASE; Maximum daily exposure: 1060 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: CAPSULE, EXTENDED RELEASE; Maximum daily exposure: 117 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: DROPS; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE; Maximum daily exposure: 629 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: GRANULE, FOR SUSPENSION; Maximum daily exposure: 14 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: INHALANT; Potency: 0.08 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: LOZENGE; Maximum daily exposure: 420 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: PELLET; Maximum daily exposure: 24 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER; Maximum daily exposure: 25 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: POWDER, FOR SUSPENSION; Maximum daily exposure: 120 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION; Maximum daily exposure: 64 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: SUSPENSION, EXTENDED RELEASE; Maximum daily exposure: 71 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET; Maximum daily exposure: 980 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE; Maximum daily exposure: 127 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, CHEWABLE, EXTENDED RELEASE; Maximum daily exposure: 9 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, COATED; Maximum daily exposure: 184 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, DELAYED RELEASE; Maximum daily exposure: 144 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, EXTENDED RELEASE; Maximum daily exposure: 173 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED; Maximum daily exposure: 96 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FILM COATED, EXTENDED RELEASE; Maximum daily exposure: 53 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, FOR SUSPENSION; Maximum daily exposure: 131 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING; Maximum daily exposure: 187 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE; Maximum daily exposure: 47 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: TABLET, SUGAR COATED; Potency: NA
- US: inactive ingredient database — Route: ORAL; Dosage form: TROCHE; Maximum daily exposure: 315 mg
- US: inactive ingredient database — Route: ORAL; Dosage form: WAFER; Potency: 66 mg
- US: inactive ingredient database — Route: RESPIRATORY (INHALATION); Dosage form: POWDER; Potency: 0.13 mg
- US: inactive ingredient database — Route: SUBCUTANEOUS; Dosage form: IMPLANT; Potency: 0.5 mg
- US: inactive ingredient database — Route: SUBLINGUAL; Dosage form: TABLET; Potency: 17.5 mg
- US: inactive ingredient database — Route: TOPICAL; Dosage form: CREAM; Potency: NA
- US: inactive ingredient database — Route: TOPICAL; Dosage form: POWDER; Maximum daily exposure: 104 mg
- US: inactive ingredient database — Route: TRANSMUCOSAL; Dosage form: LOZENGE; Maximum daily exposure: 100 mg
- US: inactive ingredient database — Route: VAGINAL; Dosage form: INSERT; Maximum daily exposure: 69 mg
- US: inactive ingredient database — Route: VAGINAL; Dosage form: RING; Maximum daily exposure: 2 mg
- US: listed in openFDA substance — openFDA substance registry classifies this ingredient as chemical.

_Assessed by Greenveil._